Restoring Confidence in the World Anti-Doping Agency Act of 2025
Summary
SB 233, the “Restoring Confidence in the World Anti-Doping Agency Act of 2025,” would amend the Office of National Drug Control Policy Reauthorization Act of 2006 to revise how the United States engages with the World Anti-Doping Agency (WADA). The bill updates statutory definitions to reflect the United States Olympic and Paralympic Committee and defines “independent athlete” to mean an amateur athlete who does not serve in specified leadership roles at the IOC, IPC, U.S. Olympic and Paralympic Committee, national governing bodies, or WADA itself.
The bill directs the Office of National Drug Control Policy (ONDCP), in consultation with U.S. anti-doping and Olympic stakeholders, to assess whether WADA has credible and independent governance, has implemented governance reforms, and provides fair decision-making roles for independent athletes from the United States and other democratic countries. If WADA is found not to meet those criteria, ONDCP must use available tools to press for compliance, report barriers to U.S. participation to Congress, and may voluntarily withhold U.S. membership dues to WADA. The bill also requires ONDCP to submit a spending plan to Congress before obligating funds to WADA.
Impact
The bill would amend federal law governing ONDCP’s authority over international anti-doping policy, specifically 21 U.S.C. 2001, by adding new oversight, reporting, and funding-review requirements related to WADA. It would also conform statutory references from the former U.S. Olympic Committee to the U.S. Olympic and Paralympic Committee and expand the role of athlete representatives in consultations. If enacted, the measure would not directly regulate athletes or sports organizations domestically, but it would change how the federal government evaluates, conditions, and potentially withholds U.S. dues and participation in WADA governance.
Sentiment
The bill appears to have bipartisan and cross-party support based on its original cosponsors, who include senators from both parties. The title and structure suggest a reform-oriented approach focused on restoring trust in international anti-doping governance and strengthening U.S. influence. No committee transcript or recorded votes were provided, so there is no direct evidence of floor debate or formal opposition in the available materials.
Contention
The main points of contention are likely to be WADA governance, U.S. representation, and the possibility of withholding dues. Supporters appear to want stronger U.S. leverage, more transparent conflict-of-interest rules, and formal decision-making roles for independent athletes from democratic countries. Potential critics could object to the bill’s pressure tactics toward an international body, the discretion to withhold membership dues, or the bill’s emphasis on U.S. representation in a multilateral anti-doping organization. The bill also narrows the definition of independent athlete, which may be debated by stakeholders concerned about who qualifies to represent athletes in governance roles.
Restoring Trade Fairness ActThis bill establishes various trade measures related to China, including by revoking China's permanent normal trade relations (PNTR) status and increasing the rates of duty (i.e., tariffs) on Chinese imported goods. The bill prohibits imported goods originating from North Korea, China, Russia, or Iran from receiving de minimis treatment. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, the bill revokes China's PNTR status. Currently, China's PNTR status allows for Chinese goods to have duty rates set forth in column 1 of the Harmonized Tariff Schedule of the United States (HTS). With the removal of China's PNTR status, the bill generally sets the applicable duty rates on imported Chinese goods at the higher rates listed in column 2 of the HTS, with exceptions.The bill establishes a minimum duty rate of 35% for all Chinese goods, which requires column 2 rates to be at least 35%. However, the bill establishes a minimum duty rate of 100% for a list of specified goods (e.g., various minerals, certain vaccines and drugs, and certain defense-related articles). Duty rates are phased in over five years and adjusted annually for inflation.The bill alsoauthorizes the President to take additional actions related to trade with China, requires merchandise imported from China to be appraised based on U.S. value, and establishes a trust fund to compensate U.S. producers for lost revenue resulting from retaliatory actions by China.